OrthoDx
OrthoDx is proud to announce its new partnership with AusDiagnostics, a leading biotechnology company that designs, manufactures, and markets a comprehensive suite of multiplexing molecular diagnostic assays and reagents.
“We are thrilled about this new partnership between AusDiagnostics and OrthoDx,” said AusDiagnostics CEO, Scott Gilroy. “Our companies share the same commitment and drive to improve patient outcomes through diagnostic innovation, and we hope this will be a long-term relationship as OrthoDx grows and expands into other areas.”
Through the partnership, AusDiagnostics will help bring the Synvichor technology to market, utilising AusDiagnostics’ patented MT-PCR techniques to deliver accurate and timely results to clinicians around the globe.
The partnership will see AusDiagnostics manufacture Synvichor and the HighPlex PCR device for worldwide supply, under a signed original equipment manufacturing (OEM) agreement.
“We are excited to be working with the team at AusDiagnostics. Their diligence, attention to detail, and high-quality workmanship have helped bring our genomic solution for joint pain to the market in record time,” said OrthoDx CEO, Dr Antony Rapisarda.
About AusDiagnostics:
AusDiagnostics Pty Ltd is a leading international company that designs, manufactures and markets a comprehensive suite of multiplexing molecular diagnostic assays and reagents. Founded in August 2006, AusDiagnostics also supports robotic instruments for in vitro diagnostics in the medical, veterinary, food, water, and environment industries. AusDiagnostics currently has 115 employees worldwide, with offices in Australia, New Zealand, the USA, and the UK. Its production facilities in Australia and UK supply a steadily growing network of more than 25 distributors and partners worldwide.
